FDA Clears Thrombolex’s Bashir Endovascular Catheter Short Basket Device – Endovascular Today
December 16, 2019—Thrombolex, Inc. announced that the company received FDA 510(k) clearance for the Bashir Endovascular Catheter—Short Bas
Related Articles
Penumbra Introduces Red 72 Silver Label Large-Bore Reperfusion Catheter – Endovascular Today
April 24, 2025—Penumbra recently announced the introduction of the Red 72 Silver Label large-bore reperfusion catheter with SendIt technology. T
CereVasc eShunt Receives Breakthrough Device Designation for Use in Pediatric Patients to Treat Communicating Hydrocephalus – Endovascular Today
April 23, 2025—CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system. Th
Imperative Care’s Zoom Stroke System Will Be Evaluated for Treatment of M2 Occlusions in Investigator-Initiated RCT – Endovascular Today
April 15, 2025—Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled trial (RCT) comparing
Perfuze’s MARRS Pivotal Trial of Millipede 088 Aspiration Catheter Completes Enrollment – Endovascular Today
April 22, 2025—Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the comple
R3 Vascular’s ELITE-BTK Pivotal Trial of Magnitude Scaffold Commences – Endovascular Today
April 22, 2025—R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn
Vivasure’s PerQseal Elite Vascular Closure System Receives CE Mark Approval – Endovascular Today
April 22, 2025—Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced European C
Results Published From TRANSCEND Study of Surmodics SurVeil DCB – Endovascular Today
April 22, 2025—Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat
IceCure ProSense Cryoablation Evaluated in Treatment for Breast Cancer – Endovascular Today
April 22, 2025—IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the
Venova Completes Enrollment in VENOS-2 Early Feasibility Study of Velocity pAVF System – Endovascular Today
April 17, 2025—Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi
VIVA Foundation Convenes Vascular Leaders Forum on Endovascular Repair for Aortic Aneurysms – Endovascular Today
April 14, 2025—With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms (